Catalyst Capital Advisors LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1549275
San Juan, PR
Position in ALNY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$15,051
+$2,148 QoQ
Shares Held
50
+28.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#668
of 784 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Catalyst Capital Advisors LLC holds $78,818 across 4 Biotechnology names. ALNY ranks #2 (19.1% of the industry book) .
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,051 | 50 | Shares | Other | 2026-07-24 | |
| 2026-03-31 | $12,903 | 39 | Shares | Other | 2026-05-06 | |
| 2025-06-30 | $147,718 | 453 | Shares | Other | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||